Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Patient-Reported Outcome Measures (PROMs) in Pediatric Non-Malignant Hematology: A Systematic Review

Robert J Klaassen, MD FRCPC, Julia Y. Kinahan, MDcal Student, Johann M. I. Graham, MDcal Student, Yamilée V. Hébert, MDcal Student, Katie O'Hearn, MSc Human Kinetics

Blood (2019) 134 (Supplement_1): 2180.

https://doi.org/10.1182/blood-2019-127248

Published: 2019

Journal Articles

Symptoms of Depression and Anxiety Assessed By the SF-36 Questionnaire in Patients with AL Amyloidosis

Stephen Lo, Janet Shu, Margot Phillips, Fangui Sun, John L Berk, Vaishali Sanchorawala

Blood (2015) 126 (23): 3299.

https://doi.org/10.1182/blood.V126.23.3299.3299

Published: 2015

Journal Articles

"Post-Pulmonary Embolism Syndrome" after a First Episode of PE: Results of the E.L.O.P.E. Study

Susan R Kahn, MD MSc, Andrew Hirsch, MD, Margaret Beddaoui, MSc, Arash Akaberi, MSc, David Anderson, MD, Philip S Wells, MDMSc, Marc Rodger, MD MSc, Susan Solymoss, MD, Michael J. Kovacs, MD, Lawrence Rudski, MD, Avi Shimony, MD, Carole Dennie, MD, Chris Rush, MD, William H. Geerts, MD, Paul Hernandez, MD, Shawn Aaron, MD, John T Granton, MD

Blood (2015) 126 (23): 650.

https://doi.org/10.1182/blood.V126.23.650.650

Published: 2015

Journal Articles

Quality of Life Outcomes Among Egyptian Children with Beta-Thalssemia

Ghada El-Kamah, MDProfessor, Soheir Adam, MDAssistant Professor, Phoebee Magdy, Assisstant Lecturer, Manal Michel, Lecturer, Hanan Afifi, MDProfessor

Blood (2014) 124 (21): 4864.

https://doi.org/10.1182/blood.V124.21.4864.4864

Published: 2014

Journal Articles

Superior Restoration of Health with Siltuximab Among Multicentric Castleman’s Disease Patients When Measured By SF-36

Frits van Rhee, MD PhD, Corey Casper, MD, Margaret K Vernon, PhD, Dylan Trundell, MSc, Don Robinson, MSPH, Jianming He, PhD, Jessica Vermeulen, MD PhD, Helgi van de Velde, MD PhD, Raymond S Wong, MD

Blood (2014) 124 (21): 4469.

https://doi.org/10.1182/blood.V124.21.4469.4469

Published: 2014

Journal Articles

Impact Of Low-Grade Adverse Events (AEs) On Health-Related Quality Of Life (HRQoL) In Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia In Chronic Phase (Ph+ CML-CP) From The Enestnd Trial: 48-Month Follow-Up

Lei Chen, MD, PhD, Annie Guerin, MSc, Maryna Marynchenko, MBA, Raluca Ionescu-Ittu, PhD, Robert Hiscock, MSc, Roy Nitulescu, MA, Chopra Pooja, MSc, Ling-I Hsu, MPH, Christopher Keir, MD, Eric Qiong Wu, PhD

Blood (2013) 122 (21): 4038.

https://doi.org/10.1182/blood.V122.21.4038.4038

Published: 2013

Journal Articles

Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population

Blood (2011) 118 (17): 4554–4560.

https://doi.org/10.1182/blood-2011-04-347575

Published: 2011

Journal Articles

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

Joseph Pidala, Brenda Kurland, Xiaoyu Chai, Navneet Majhail, Daniel J. Weisdorf, Steven Pavletic, Corey Cutler, David Jacobsohn, Jeanne Palmer, Sally Arai, Madan Jagasia, Stephanie J. Lee

Blood (2011) 117 (17): 4651–4657.

https://doi.org/10.1182/blood-2010-11-319509

Published: 2011

Includes: Supplemental data

Journal Articles

Effect of Mild Hemophilia A on Quality of Life Using the SF-36.

Meghan C. Walsh, PhD, David Macgregor, CGC, Brendan Barrett, MD, Susan Stuckless, MSc, Marc Kawaja, MSc, Mary-Frances Scully, MD

Blood (2006) 108 (11): 5537.

https://doi.org/10.1182/blood.V108.11.5537.5537

Published: 2006

Journal Articles

Long-Term Abnormalities of Patient-Reported Outcomes after Recovery from Thrombotic Thrombocytopenic Purpura (TTP) Using Health Related Quality-of-Life (QOL) Measurements.

Qurana Lewis, MPH, Deirdra R. Terrell, MPH, Sara K. Vesely, PhD, James N. George, MD

Blood (2006) 108 (11): 458.

https://doi.org/10.1182/blood.V108.11.458.458

Published: 2006

Journal Articles

Quality of Life (QoL) Impairment and International Prognostic Index (IPI) in New Aggressive Non-Hodgkin’s Lymphoma (ANHL) Patients.

Andrei A. Novik, Tatiana I. Ionova, PhD, Anton V. Kishtovich, PhD, Alexander A. Myasnikov, Tatiana V. Chagorova, MD, PhD, Mikhail V. Kopp, Nina E. Osipova, MD, Julia K. Lebedeva, MD, Natalia N. Malakchova, MD, Anastasia V. Pankova, Denis A. Fedorenko, MD, PhD, Gary I. Gorodokin, MD

Blood (2005) 106 (11): 4651.

https://doi.org/10.1182/blood.V106.11.4651.4651

Published: 2005

Journal Articles

Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation

David C. Seldin, Jennifer J. Anderson, Vaishali Sanchorawala, Karim Malek, Daniel G. Wright, Karen Quillen, Kathleen T. Finn, John L. Berk, Laura M. Dember, Rodney H. Falk, Martha Skinner

Blood (2004) 104 (6): 1888–1893.

https://doi.org/10.1182/blood-2004-01-0089

Published: 2004

Includes: Supplemental data

Journal Articles

Health-related quality of life of unrelated bone marrow donors in Japan

Mina Nishimori, Yoshitsugu Yamada, Keiko Hoshi, Yuichi Akiyama, Yasutaka Hoshi, Yasuo Morishima, Masahiro Tsuchida, Shunichi Fukuhara, Yoshihisa Kodera

Blood (2002) 99 (6): 1995–2001.

https://doi.org/10.1182/blood.V99.6.1995

Published: 2002

NARROW

Patient-Reported Outcome Measures (PROMs) in Pediatric Non-Malignant Hematology: A Systematic Review

Symptoms of Depression and Anxiety Assessed By the SF-36 Questionnaire in Patients with AL Amyloidosis

"Post-Pulmonary Embolism Syndrome" after a First Episode of PE: Results of the E.L.O.P.E. Study

Quality of Life Outcomes Among Egyptian Children with Beta-Thalssemia

Superior Restoration of Health with Siltuximab Among Multicentric Castleman’s Disease Patients When Measured By SF-36

Impact Of Low-Grade Adverse Events (AEs) On Health-Related Quality Of Life (HRQoL) In Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia In Chronic Phase (Ph+ CML-CP) From The Enestnd Trial: 48-Month Follow-Up

Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

Effect of Mild Hemophilia A on Quality of Life Using the SF-36.

Long-Term Abnormalities of Patient-Reported Outcomes after Recovery from Thrombotic Thrombocytopenic Purpura (TTP) Using Health Related Quality-of-Life (QOL) Measurements.

Quality of Life (QoL) Impairment and International Prognostic Index (IPI) in New Aggressive Non-Hodgkin’s Lymphoma (ANHL) Patients.

Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation

Health-related quality of life of unrelated bone marrow donors in Japan

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only